Inhibition of D4 dopamine receptors on insulin receptor expression and effect in renal proximal tubule cells

Journal of the American Heart Association

Volumn 5, Issue 4, 2016, Pages

  Zhang, Ye ^a,b   Ren, Hongmei ^a,b   Lu, Xi ^a,b   He, Duofen ^a,b   Han, Yu ^a,b   Wang, Hongyong ^a,b   Zeng, Chunyu ^a,b   Shi, Weibin ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing Institute of Cardiology   (China)

Author keywords

Dopamine receptor; Hypertension; Insulin; Renal proximal tubule cells

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 2 AMINOETHOXYDIPHENYLBORANE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DOPAMINE 4 RECEPTOR; INSULIN RECEPTOR; N [4 (2 CYANOPHENYL) 1 PIPERAZINYLMETHYL] 3 METHYLBENZAMIDE; NICARDIPINE; SMALL INTERFERING RNA; BENZAMIDE DERIVATIVE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; N-((4-(2-CYANOPHENYL)-1-PIPERAZINYL)METHYL)-3-METHYLBENZAMIDE; PIPERAZINE DERIVATIVE; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL IMMORTALIZATION; CELL LYSATE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; EXTRACELLULAR CALCIUM; IMMUNOBLOTTING; INCUBATION TIME; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HYPERTENSION; INTRACELLULAR FLUID; METABOLISM; PATHOLOGY; WISTAR KYOTO RAT;

ANIMALS; BENZAMIDES; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HYPERTENSION; IMMUNOBLOTTING; INTRACELLULAR FLUID; KIDNEY TUBULES, PROXIMAL; PIPERAZINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, INSULIN; RECEPTORS, DOPAMINE D4; RNA;

EID: 84995598433     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.002448     Document Type: Article

References (42)

1. Rosendorff C. Hypertension and coronary artery disease: a summary of the American Heart Association scientific statement. J Clin Hypertens (Greenwich). 2007;9:790-795.
2. McDonough AA, Biemesderfer D. Does membrane trafficking play a role in regulating the sodium/hydrogen exchanger isoform 3 in the proximal tubule? Curr Opin Nephrol Hypertens. 2003;12:533-541.
3. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood). 2003;228:134-142.
4. Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol. 2004;286:H1597-H1602.
5. Wei Y, Chen K, Whaley-Connell AT, Stump CS, Ibdah JA, Sowers JR. Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. Am J Physiol Regul Integr Comp Physiol. 2008;294:R673-R680.
6. Baum M. Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest. 1987;79:1104-1109.
7. 1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression. J Hypertens. 2009;27:1033-1041.
8. 1 receptor effect and enhanced Na, K-ATPase affinity for sodium in proximal tubule of streptozotocin-treated diabetic rats. Clin Exp Hypertens. 2007;29:435-444.
9. 2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1071-R1078.
10. Tsuchida H, Imai G, Shima Y, Satoh T, Owada S. Mechanism of sodium loadinduced hypertension in non-insulin dependent diabetes mellitus model rats: defective dopaminergic system to inhibit Na-K-ATPase activity in renal epithelial cells. Hypertens Res. 2001;24:127-135.
11. 2 receptors simultaneously ameliorates various metabolic features of obese women. Am J Physiol Endocrinol Metab. 2006;291: E1038-E1043.
12. Umrani DN, Goyal RK. Fenoldopam treatment improves peripheral insulin sensitivity and renal effect in STZ-induced type 2 diabetic rats. Clin Exp Hypertens. 2003;25:221-233.
13. 2-like dopamine receptors in the kidney of the spontaneously hypertensive rat. J Hypertens. 2003;21:199-207.
14. Parenti A, Cui XL, Hopfer U, Ziche M, Douglas JG. Activation of MAPKs in proximal tubule cells from spontaneously hypertensive and control Wistar-Kyoto rats. Hypertension. 2000;35:1160-1166.
15. + exchanger interactions in the kidney in hypertension. Hypertension. 2000;36:395-399.
16. Woost PG, Orosz DE, Jin W, Frisa PS, Jacobberger JW, Douglas JG, Hopfer U. Immortalization and characterization of proximal tubule cells derived from kidneys of spontaneously hypertensive and normotensive rats. Kidney Int. 1996;50:125-134.
17. 3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res. 2006;99:494-500.
18. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999;283:1544-1548.
19. 4 receptors in prefrontal cortex. Mol Pharmacol. 2004;66:948-955.
20. Tanaka K, Okada Y, Kanno T, Otomo A, Yanagisawa Y, Shouguchi-Miyata J, Suga E, Kohiki E, Onoe K, Osuga H, Aoki M, Hadano S, Itoyama Y, Ikeda JE. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice. Exp Neurol. 2008;211:378-386.
21. 4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Hypertension. 2015;65:153-160.
22. 2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis. Br J Pharmacol. 2007;151:1176-1186.
23. Johnson EA, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall KJ, Mundell SJ, Bailey CP, Kelly E, Henderson G. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells. Mol Pharmacol. 2006;70:676-685.
24. Bobalova J, Mutafova-Yambolieva VN. Activation of the adenylyl cyclase/ protein kinase A pathway facilitates neural release of beta-nicotinamide adenine dinucleotide in canine mesenteric artery. Eur J Pharmacol. 2006;536: 128-132.
25. Lei J, Mariash CN, Bhargava M, Wattenberg EV, Ingbar DH. T3 increases Na-KATPase activity via a MAPK/ERK1/2-dependent pathway in rat adult alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2008;294:L749-L754.
26. + current via activation of a cyclic AMP/protein kinase A pathway in nociceptor-like rat dorsal root ganglion cells. Neuroscience. 2011;186:13-20.
27. + channels in marginal cells in the stria vascularis of guinea pigs. J Physiol Sci. 2007;57:287-298.
28. + release from the endoplasmic reticulum in renal proximal tubule cells. Hypertens Res. 2009;32:846-852.
29. +-ATPase parallels the increase in sodium transport and potassium recycling in an in vitro model of proximal tubule cellular ageing. J Membr Biol. 2006;212:163-175.
30. Atchley DW, Loeb RF, Richards DW, Benedict EM, Driscoll ME. On diabetic acidosis: a detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy. J Clin Invest. 1933;12:297-326.
31. Millar JH, Bogdonoff MD. Antidiuresis associated with administration of insulin. J Appl Physiol. 1954;6:509-512.
32. Segers O, Anckaert E, Gerlo E, Dupont AG, Somers G. Dopamine-sodium relationship in type 2 diabetic patients. Diabetes Res Clin Pract. 1996;34:89-98.
33. 1 receptor dyseffect is acquired and not inherited in obese Zucker rats. Am J Physiol Renal Physiol. 2004;287:F109-F116.
34. Banday AA, Asghar M, Hussain T, Lokhandwala MF. Dopamine-mediated inhibition of renal Na. K-ATPase is reduced by insulin. Hypertension. 2003;41:1353-1358.
35. Rosen OM, Herrera R, Olowe Y, Petruzzelli LM, Cobb MH. Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc Natl Acad Sci USA. 1983;80:3237-3240.
36. Yu KT, Czech MP. Tyrosine phosphorylation of the insulin receptor beta subunit activates the receptor-associated tyrosine kinase activity. J Biol Chem. 1984;259:5277-5286.
37. Czech MP. The nature and regulation of the insulin receptor: structure and function. Annu Rev Physiol. 1985;47:357-381.
38. Mamula PW, Wong KY, Maddux BA, McDonald AR, Goldfine ID. Sequence and analysis of promoter region of human insulin-receptor gene. Diabetes. 1988;37:1241-1246.
39. McKeon C. Transcriptional regulation of the insulin receptor gene promoter. Adv Exp Med Biol. 1993;343:79-89.
40. Apt D, Watts RM, Suske G, Bernard HU. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology. 1996;224:281-291.
41. You HL, Eng HL, Hsu SF, Chen CM, Ye TC, Liao WT, Huang MY, Baer R, Cheng JT. A PKC-Sp1 signaling pathway induces early differentiation of human keratinocytes through upregulation of TSG101. Cell Signal. 2007;19:1201-1211.
42. 2+. Evidence for an interactive role of cAMP regulatory element-binding protein and Sp1. J Biol Chem. 2005;280:334-346.